![Keith Orford](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Orford
Keine laufenden Positionen mehr
Profil
Keith Orford worked at Calithera Biosciences, Inc. from 2015 to 2023, serving as Non-Independent Director from 2021 to 2023.
Worked at Parabilis Medicines, Inc. as Chief Medical Officer & Executive VP-Clinical.
Worked at GSK Plc from 2010 to 2015, serving as Clinical Development Lead-Immuno-Oncology from 2013 to 2015.
Ehemalige bekannte Positionen von Keith Orford
| Unternehmen | Position | Ende |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.11.2021 |
| GSK PLC | Corporate Officer/Principal | 01.01.2015 |
| PARABILIS MEDICINES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Keith Orford
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calithera Biosciences, Inc.
 Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
